PER1 and central nervous system cancer: Many of the core circadian rhythm PAS factors, including the period (PER) genes, are downregulated in breast, colorectal, prostate, glioma and non-small cell lung cancer in humans; moreover, it has been suggested that PER1 and PER2 function as tumor suppressors [86–91].